(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2

Names

[ CAS No. ]:
478506-38-6

[ Name ]:
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2

[Synonym ]:
L-Sorbose-6-13C

Biological Activity

[Description]:

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 is the 13C labeled (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one. (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is an endogenous metabolite[1].

[Related Catalog]:

Research Areas >> Others

[In Vitro]

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

[References]

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

Chemical & Physical Properties

[ Molecular Formula ]:
C6H12O6

[ Molecular Weight ]:
181.14900

[ Exact Mass ]:
181.06700

[ PSA ]:
110.38000

Related Compounds